Novel Perspectives on the Design and Development of a Long-Acting Subcutaneous Raltegravir Injection for Treatment of HIV—In Vitro and In Vivo Evaluation

Antiretrovirals (ARVs) are a highly effective therapy for treatment and prevention of HIV infection, when administered as prescribed. However, adherence to lifelong ARV regimens poses a considerable challenge and places HIV patients at risk. Long-acting ARV injections may improve patient adherence a...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Heba S. Abd-Ellah, Ramesh Mudududdla, Glen P. Carter, Jonathan B. Baell
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2023-05-01
Ráidu:	Pharmaceutics
Fáttát:	HIV long-acting subcutaneous injection raltegravir cyclisation-activated prodrugs
Liŋkkat:	https://www.mdpi.com/1999-4923/15/5/1530
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!